Neonatal, infant, and childhood growth following metformin versus insulin treatment for gestational diabetes: A systematic review and meta-analysis
Open accessThe DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Metformin is increasingly offered as an acceptable and economic alternative to insulin for treatment of gestational diabetes mellitus (GDM) in many countries. However, the impact of maternal metformin treatment on the trajectory of fetal, infant, and childhood growth is unknown. METHODS AND FINDINGS: PubMed, Ovid Embase, Medline, Web of Science, ClinicalTrials.gov, and the Cochrane database were systematically searched (from database inception to 26 February 2019). Outcomes of GDM-affected pregnancies randomised to treatment with metformin versus insulin were included (randomised controlled trials and prospective randomised controlled studies) from cohorts including European, American, Asian, Australian, and African women. Studies including pregnant women with pre-existing diabetes or non-diabetic women were excluded, as were trials comparing metformin treatment with oral glucose-lowering agents other than insulin. Two reviewers independently assessed articles for eligibility and risk of bias, and conflicts were resolved by a third reviewer. Outcome measures were parameters of fetal, infant, and childhood growth, including weight, height, BMI, and body composition. In total, 28 studies (n = 3,976 participants) met eligibility criteria and were included in the meta-analysis. No studies reported fetal growth parameters; 19 studies (n = 3,723 neonates) reported measures of neonatal growth. Neonates born to metformin-treated mothers had lower birth weights (mean difference -107.7 g, 95% CI -182.3 to -32.7, I2 = 83%, p = 0.005) and lower ponderal indices (mean difference -0.13 kg/m3, 95% CI -0.26 to 0.00, I2 = 0%, p = 0.04) than neonates of insulin-treated mothers. The odds of macrosomia (odds ratio [OR] 0.59, 95% CI 0.46 to 0.77, p < 0.001) and large for gestational age (OR 0.78, 95% CI 0.62 to 0.99, p = 0.04) were lower following maternal treatment with metformin compared to insulin. There was no difference in neonatal height or incidence of small for gestational age between groups. Two studies (n = 411 infants) reported measures of infant growth (18-24 months of age). In contrast to the neonatal phase, metformin-exposed infants were significantly heavier than those in the insulin-exposed group (mean difference 440 g, 95% CI 50 to 830, I2 = 4%, p = 0.03). Three studies (n = 520 children) reported mid-childhood growth parameters (5-9 years). In mid-childhood, BMI was significantly higher (mean difference 0.78 kg/m2, 95% CI 0.23 to 1.33, I2 = 7%, p = 0.005) following metformin exposure than following insulin exposure, although the difference in absolute weights between the groups was not significantly different (p = 0.09). Limited evidence (1 study with data treated as 2 cohorts) suggested that adiposity indices (abdominal [p = 0.02] and visceral [p = 0.03] fat volumes) may be higher in children born to metformin-treated compared to insulin-treated mothers. Study limitations include heterogeneity in metformin dosing, heterogeneity in diagnostic criteria for GDM, and the scarcity of reporting of childhood outcomes. CONCLUSIONS: Following intrauterine exposure to metformin for treatment of maternal GDM, neonates are significantly smaller than neonates whose mothers were treated with insulin during pregnancy. Despite lower average birth weight, metformin-exposed children appear to experience accelerated postnatal growth, resulting in heavier infants and higher BMI by mid-childhood compared to children whose mothers were treated with insulin. Such patterns of low birth weight and postnatal catch-up growth have been reported to be associated with adverse long-term cardio-metabolic outcomes. This suggests a need for further studies examining longitudinal perinatal and childhood outcomes following intrauterine metformin exposure. This review protocol was registered with PROSPERO under registration number CRD42018117503.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures















Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A follow-up study at 5-10 years showed that the offspring had higher BMI, weight-toheight ratios, waist circumferences, and a borderline increase in fat mass (88,89).”
From 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024 (2024) · cites this paper as [88]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“A meta-analysis demonstrated that metformin exposure resulted in smaller neonates with an acceleration of postnatal growth, resulting in higher BMI in childhood (88).”
From 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024 (2024) · cites this paper as [88]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
Scottish Intercollegiate Guidelines Network
Twaddle, S., & Qureshi, S. (2005) · Evidence-based Healthcare and Public Health · doi:10.1016/j.ehbc.2005.09.008 · Cited by 4,084
Elective induction versus spontaneous labor after sonographic diagnosis of fetal macrosomia.
Combs, C. A., Singh, N. B., & Khoury, J. C. (1993) · PubMed · Cited by 2,500
OWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157
Association between postnatal catch-up growth and obesity in childhood: prospective cohort study
Ong, K. K. L. (2000) · BMJ · doi:10.1136/bmj.320.7240.967 · Cited by 1,668
Metformin versus insulin for the treatment of gestational diabetes
Rowan, J. A., Hague, W. M., Gao, W., Battin, M. R., & Moore, M. P. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707193 · Cited by 1,291
Prevalence of Gestational Diabetes and Risk of Progression to Type 2 Diabetes: a Global Perspective
Zhu, Y., & Zhang, C. (2016) · Current Diabetes Reports · doi:10.1007/s11892-015-0699-x · Cited by 1,260
Research works printed but not linked: 2
- Hamadani A, Zahid S, Butt ZB. Metformin versus insulin treatment in gestational diabetes in pregnancy and their effects on neonatal birthweight. Pak J Med Sci. 2017; 11: 914– 6.
- International Diabetes Federation. IDF diabetes atlas— 8th edition Brussels: International Diabetes Federation; 2017.
Cited by
Items 201–269 of 269
Soares, G. G., Azevedo, M. D. A., de Jesus, B. M. L., Vieira, G. S., & Bristot, M. (2023) · Inova Saúde · doi:10.18616/inova.v14i3.8028 · Cited by 2
Temas de guardia en medicina: Volumen 1
SAS), R. E. L. D. I. C. (. (2023) · doi:10.58995/lb.redlic.19
Etiología, diagnóstico y tratamiento de la resistencia a la insulina. Revisión sistemática
González, C. R. C., & Gutiérrez, M. S. C. (2023) · doi:10.58995/lb.redlic.19.166
Metformin in pregnancy: everything you always wanted to know but were afraid to ask
Biamonte, E. (2023) · The Journal of AMD · doi:10.36171/jamd23.26.3.4
Features of Hypoglycemic Pharmacotherapy of Gestational Diabetes Mellitus
Чак, Т. А., Высоцкая, Ю. В., Романова, И. С., & Кожанова, И. Н. (2023) · Рецепт · doi:10.34883/pi.2023.26.6.011
Rozance, P. J., Brown, L. D., & Wesolowski, S. R. (2024) · Reproductive Sciences · doi:10.1007/s43032-024-01547-2
“Concern-ingly, emerging studies in human cohorts report adverse effects in offspring exposed to intrauterine metformin including decreased birth weight and increased risk for childhood adiposity [1, 5, 6].”
BackgroundRadhakrishnan, A., Surya, B., & Ethirajan, S. (2024) · Indian Journal of Obstetrics and Gynecology Research · doi:10.18231/j.ijogr.2024.076
Hummel, M., Füchtenbusch, M., Battefeld, W., Bührer, C., Groten, T., Haak, T., Kainer, F., Kautzky‐Willer, A., Lechner, A., Meißner, T., et al. (2024) · Diabetologie und Stoffwechsel · doi:10.1055/a-2312-0352
“Daten für die optimale Gewichtszunahme im Vergleich zu einer Gewichtserhaltung bei Frauen mit BMI >35kg/m 2 fehlen [65].”
Zhu, X., Wang, W., Yang, Y., Zhou, H., Long, W., & Zhang, B. (2024) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-024-01522-3
ALTUNAY, F. K. (2024) · Bidge Yayınları eBooks · doi:10.70269/10.70269/5786955648
Prenatal Diagnosis and Surgical Approach in Placenta Accreta Spectrum
Karabay, G. (2024) · Bidge Yayınları eBooks · doi:10.70269/10.70269/9739972682
Postpartum Kanamalarda İnternal İliak Arter Ligasyonu
KAYA, H. (2024) · Bidge Yayınları eBooks · doi:10.70269/10.70269/2268974953
EROĞLU, H. (2024) · Bidge Yayınları eBooks · doi:10.70269/10.70269/5828872562
Turan, Z. (2024) · Bidge Yayınları eBooks · doi:10.70269/10.70269/9826164186
Englund‐Ögge, L., Hellman, J., BACKMAN, H. E., Drevin, J., Melander, E., Sundell, E., & Hansson, M. (2025) · medRxiv · doi:10.1101/2025.04.02.25325122
“Although metformin use is considered safe for mothers, concerns persist regarding its long-term metabolic effects on children exposed to the drug in utero, as metformin, unlike insulin, crosses the placenta (17).”
Enrique Valdés, R. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1007644
Hummel, M., Füchtenbusch, M., Battefeld, W., Bührer, C., Groten, T., Haak, T., Kainer, F., Kautzky‐Willer, A., Lechner, A., Meißner, T., et al. (2025) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-2499-9780
“Currently, metformin therapy in pregnant women with type 2 diabetes is being studied in 2 trials (MiTy and MOMPOD) [65].”
Hummel, M., Füchtenbusch, M., Battefeld, W., Bührer, C., Groten, T., Haak, T., Kainer, F., Kautzky‐Willer, A., Lechner, A., Meißner, T., et al. (2025) · Die Diabetologie · doi:10.1007/s11428-025-01313-1
Neonatal and Childhood Consequences of Maternal Obesity and Diabetes
Hulst, A. V., Savard, C., Harnois‐Leblanc, S., Gingras, V., & Henderson, M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-23940-3.00016-8
Boriboonhirunsarn, D., & Sunsaneevithayakul, P. (2025) · JMIR Research Protocols · doi:10.2196/79855 · Cited by 1
Gordon, H. G., Salim, N., Tong, S., Walker, S. P., Silva, M. D., Cluver, C. A., Mehdipour, P., Hiscock, R. J., Sutherland, L., Doust, A. M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.27123844
Gordon, H. G., Salim, N., Tong, S., Walker, S. P., Silva, M. D., Cluver, C. A., Mehdipour, P., Hiscock, R. J., Sutherland, L., Doust, A. M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.27123847
Semertzidou, A., Grout-Smith, H., Kalliala, I. E. J., Garg, A., Terzidou, V., Marchesi, J. R., MacIntyre, D. A., Bennett, P. R., Tsilidis, K. K., & Kyrgiou, M. (2023) · Figshare · doi:10.6084/m9.figshare.22655484
Semertzidou, A., Grout-Smith, H., Kalliala, I. E. J., Garg, A., Terzidou, V., Marchesi, J. R., MacIntyre, D. A., Bennett, P. R., Tsilidis, K. K., & Kyrgiou, M. (2023) · Figshare · doi:10.6084/m9.figshare.22655499
Gordon, H. G., Salim, N., Tong, S., Walker, S. P., Silva, M. D., Cluver, C. A., Mehdipour, P., Hiscock, R. J., Sutherland, L., Doust, A. M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.27123850
Semertzidou, A., Grout-Smith, H., Kalliala, I. E. J., Garg, A., Terzidou, V., Marchesi, J. R., MacIntyre, D. A., Bennett, P. R., Tsilidis, K. K., & Kyrgiou, M. (2023) · Figshare · doi:10.6084/m9.figshare.22655508
Semertzidou, A., Grout-Smith, H., Kalliala, I. E. J., Garg, A., Terzidou, V., Marchesi, J. R., MacIntyre, D. A., Bennett, P. R., Tsilidis, K. K., & Kyrgiou, M. (2023) · Figshare · doi:10.6084/m9.figshare.22655511
Semertzidou, A., Grout-Smith, H., Kalliala, I. E. J., Garg, A., Terzidou, V., Marchesi, J. R., MacIntyre, D. A., Bennett, P. R., Tsilidis, K. K., & Kyrgiou, M. (2023) · Figshare · doi:10.6084/m9.figshare.22655481
Semertzidou, A., Grout-Smith, H., Kalliala, I. E. J., Garg, A., Terzidou, V., Marchesi, J. R., MacIntyre, D. A., Bennett, P. R., Tsilidis, K. K., & Kyrgiou, M. (2023) · Figshare · doi:10.6084/m9.figshare.22655505
Semertzidou, A., Grout-Smith, H., Kalliala, I. E. J., Garg, A., Terzidou, V., Marchesi, J. R., MacIntyre, D. A., Bennett, P. R., Tsilidis, K. K., & Kyrgiou, M. (2023) · Figshare · doi:10.6084/m9.figshare.22655496
Semertzidou, A., Grout-Smith, H., Kalliala, I. E. J., Garg, A., Terzidou, V., Marchesi, J. R., MacIntyre, D. A., Bennett, P. R., Tsilidis, K. K., & Kyrgiou, M. (2023) · Figshare · doi:10.6084/m9.figshare.22655493
Semertzidou, A., Grout-Smith, H., Kalliala, I. E. J., Garg, A., Terzidou, V., Marchesi, J. R., MacIntyre, D. A., Bennett, P. R., Tsilidis, K. K., & Kyrgiou, M. (2023) · Figshare · doi:10.6084/m9.figshare.22655487
Semertzidou, A., Grout-Smith, H., Kalliala, I. E. J., Garg, A., Terzidou, V., Marchesi, J. R., MacIntyre, D. A., Bennett, P. R., Tsilidis, K. K., & Kyrgiou, M. (2023) · Figshare · doi:10.6084/m9.figshare.22655490
Semertzidou, A., Grout-Smith, H., Kalliala, I. E. J., Garg, A., Terzidou, V., Marchesi, J. R., MacIntyre, D. A., Bennett, P. R., Tsilidis, K. K., & Kyrgiou, M. (2023) · Figshare · doi:10.6084/m9.figshare.22655502
Xie, X. (2020) · Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona)
Elito, J., & Júnior, E. A. (2025) · Directory of Open access Books (OAPEN Foundation)
Metformin versus insulin in gestational diabetes – long-term effects on child at the age of 9 years
Paavilainen, E. (2024) · UTUPub (University of Turku)
Hummel, M., Füchtenbusch, M., Battefeld, W., Bührer, C., Groten, T., Haak, T., Kainer, F., Kautzky‐Willer, A., Lechner, A., Meissner, T., et al. (2025) · Diabetologie und Stoffwechsel · doi:10.1055/a-2592-7979
Metformin Antibacterial Activity on Vaginal Isolates in Polycystic Ovarian Syndrome
Salman, H. D. (2025) · Academia Open · doi:10.21070/acopen.10.2025.13026
Liu, Y., Rong, L., Ailikaiti, A., Zhao, X., Zhang, W., & Wang, H. (2026) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2026.111927
Sun, L., Du, P., & Xi, Z. (2026) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-026-08649-6 · Cited by 3
Su, S., Liu, J., Zhang, Y., Xie, S., Yue, W., Liu, R., Yin, C., & Zhang, E. (2026) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-026-02120-4 · Cited by 1
“Consistent with previous findings, GDM-TC women had lower risk of pregnancy complications [19–23].”
Goedeke, S. M. (2024) · Tuwhera (Auckland University of Technology)
Hummel, M., Füchtenbusch, M., Battefeld, W., Bührer, C., Groten, T., Haak, T., Kainer, F., Kautzky‐Willer, A., Lechner, A., Meißner, T., et al. (2026) · Die Diabetologie · doi:10.1007/s11428-026-01448-9
Advances in Research on Childhood‐Obesity Associated With Gestational Diabetes Mellitus
Chen, W., Xi, M., Li, S., Li, L., Zhang, D., Gong, M., Zhao, Y., & Wu, N. (2026) · Journal of Diabetes · doi:10.1111/1753-0407.70212 · Cited by 1
Velázquez, C. (2025) · Repositorio Digital Institucional de la Universidad de Buenos Aires (Universidad de Buenos Aires)
Scairati, R., Newman, C., Alvarez‐Iglesias, A., Smyth, A., O’Shea, P. M., Devane, D., Gillespie, P., Egan, A. M., O'Donnell, M. J., & Dunne, F. (2026) · Trials · doi:10.1186/s13063-026-09703-6 · Cited by 1
“By contrast, meta-analytic evidence has reported lower birthweight with postnatal catch-up growth and higher body mass index (BMI) in mid-childhood among metformin-exposed offspring [21].”
Bhujbal, M. P., Dwivedi, J., Rane, P. B., & Mayadeo, N. (2026) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20261263
Shrestha, K. S., Jensen, C. E., Boggess, K. A., Ramos, G. A., & Battarbee, A. N. (2026) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2026.04.043
Yu, R., Liu, X., & Zhang, S. (2026) · BMC Medical Genomics · doi:10.1186/s12920-026-02401-x
“Statistical analyses were conducted using GraphPad Prism 9.3.1 and IBM SPSS Statistics 23.”
InfluentialAbdali, A. M., Tauma, R. J., Hussein, S. R. M., AlAasam, A. I., & Nasrawi, A. J. M. (2026) · International Journal of Clinical Obstetrics and Gynaecology Nexovation · doi:10.54660/.ijcogn.2026.2.2.35-40
Sparić, R., Stojković, M., Babović, I. R., Plešinac, J., Pavlović, N., Simanić, S., & Plešinac, S. (2026) · Srpski medicinski casopis Lekarske komore · doi:10.5937/smclk7-66736
“Dugoročni kardiometabolički efekti ove izloženosti ostaju neutvrđeni [49,50].”
Arenas, G. A., Herrera, E. A., Krause, B. J., Giussani, D. A., Julian, C. G., MOORE, L. G., & Lorca, R. A. (2026) · Physiological Reviews · doi:10.1152/physrev.00003.2026 · Cited by 1
Metformin and Hypertensive Disorders of Pregnancy: A Phenotype-Based Focused Narrative Review
Ivanović, K., Dugalić, S., Gojnić-Dugalić, M., & Milinčić, M. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15166423
“…differences in comparator groups, variable metformin dose and duration, and relatively short follow-up compared with the life course over which cardiometabolic disease develops [19–21 ,32 38 The appropriate clinical position is therefore neither unrestricted use nor categorical avoidance.”
InfluentialMetformin Exposure in Pregnancy and Fetal Programming: A Focused Review of Contemporary Evidence
Gojnić-Dugalić, M., Dugalić, S., Milinčić, M., & Ivanović, K. (2026) · Biomedicines · doi:10.3390/biomedicines14081867
Rate and Characteristics of Metformin Use in Gestational Diabetes
Techawijittra, T., & Boriboonhirunsarn, D. (2026) · Obstetrics and Gynecology International · doi:10.1155/ogi/1243724
Guía de manejo clínico para la diabetes gestacional. Sociedad Chilena de Diabetología (SOCHIDIAB)
Strodthoff, K., Pérez-Zavala, C., Contreras-Millán, A., González-Zenteno, C., Hernández-Maetschl, S., Duarte-Silva, L., Del-Favero-Tocornal, M., Díaz-Canepa, M., Elgueta-Rodríguez, K. I., Figueroa-Ponce, M., et al. (2026) · Revista chilena de nutrición · doi:10.64159/rchnut-53-4-9
Maternal metformin treatment in obese pregnant dams normalizes neonatal sensory-motor reflexes
Müller-Limberger, E., Frederick, B., Hansen, S., Wohlfarth, M., Janoschek, R., Mahabir, E., Fischer, P., Gründemann, D., Kalis, S., Alcazar, M. A. A., et al. (2026) · Molecular and Cellular Pediatrics · doi:10.1186/s40348-026-00259-8
“…suggest a partial rescue through maternal metformin treatment, both FGR and rapid postnatal growth have been linked to an increased risk of obesity and metabolic disorders later in life [57, 58], underscoring the need for long-term monitoring of growth trajectories in metformin-exposed offspring.”
Metformin Exposure in Pregnancy and Childhood Developmental Outcomes
Gordon, H., Hiscock, R. J., Price, S., Shub, A., Mitchell, A. R., Atkinson, J., Walker, S. P., Forsythe, A., Tong, S., Lindquist, A., et al. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2026.37054
Nehls, V. G., Foresti, N. C., Almeida, L. G., & Miotti, L. V. (2025) · Revista Rede de Cuidados em Saúde
Cabar, F. R., & da Costa, R. A. (2026) · HEC Forum · doi:10.1007/s10730-026-09619-3
Metabolic homeostasis and women’s reproductive health
Liu, X., 杨利丽, Jiang, J., Chang, H., & Mu, L. (2026) · Nature Metabolism · doi:10.1038/s42255-026-01646-1 · Cited by 1
Long-term impact of gestational diabetes mellitus on the health in mothers
Shen, G. X., Ludwig, S. M., Salamon, E. A., & McIntyre, D. H. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-13265-0.00017-3
Oral hypoglycemic medications for GDM treatment
Lindsay, R. S., & Mackin, S. T. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-13265-0.00019-7
Vakili, V. (2026) · Research Square · doi:10.21203/rs.3.rs-11179852/v1
Perichart‐Perera, O., Hernández‐Hernández, L., & Rodríguez-Cano, A. M. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.71471
Recomendaciones sobre «qué no hacer» en la consulta con los pacientes con diabetes mellitus tipo 2
Trébo, F. G. (2026) · Diabetes práctica · doi:10.52102/diabet/pract.2026.1.art3
Metadata
- Authors
- Tarry-Adkins, J. L., Aiken, C. E., & Ozanne, S. E.
- Affiliations
- University of Cambridge (GB)
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2019-08-06
- Volume
- 16
- Issue
- 8
- Pages
- e1002848
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC6684046
- OpenAlex
- W2963238421
- Cited by
- 251
- References
- 77
- Citations by year
- 2026: 25 · 2025: 28 · 2024: 37 · 2023: 59 · 2022: 35 · 2021: 41 · 2020: 23 · 2019: 3
- FWCI
- 4.03
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Apollo
- Funders
- British Heart Foundation (RG/17/12/33167)
- Medical Research Council (MC_ UU_12012/4)
- Addenbrooke's Charitable Trust, Cambridge University Hospitals (GB)
- Isaac Newton Trust
- Wellcome Trust
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Keywords
- gestational diabetes mellitus, metformin, insulin therapy, neonatal growth, infant growth, child growth, birth weight, macrosomia, large for gestational age, small for gestational age, body composition, fetal growth, childhood obesity risk, child height, child weight gain, childhood adiposity
- MeSH terms
- Child Development, Child, Preschool, Female, Humans, Hypoglycemic Agents, Infant, Infant, Newborn, Insulin, Metformin, Pregnancy, Diabetes, Gestational
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.